Somanta

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...technology Business into Tekmira Pharmaceuticals II-50 MilleGen Enters into Collaboration with LFB II-50 Access Pharmaceuticals to Acquire somanta II-50 TopoTarget to Acquire Apoxis SA II-51 Genentech Inks Exclusive Global Licensing Agreement with Seattle Genetics II-51 Celgene Ag...

Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries

...l success, our ability to successfully develop marketed products and the ability to obtain or meet the closing conditions in the merger agreement with somanta Pharmaceuticals, Inc. and applicable regulatory and tax requirements, and to otherwise complete the merger in a timely manner. These statements are su...

Somanta in Medical Technology

Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference

Pre-clinical Data Suggests Angiolix Can Inhibit Breast Cancer Growth By 75% DALLAS and IRVINE, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (Bulletin Board: ACCP) and Somanta Pharmaceuticals, Inc. (Bulletin Board: SMPM) announced today that a scientific abstract out...

Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin

...r agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to n...he closing conditions in the merger agreement with somanta Pharmaceuticals, Inc. and applicable regulatory an... Form 10-KSB and other reports filed by Access and somanta with the Securities and Exchange Commission. ...

Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference

...r agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to n...he closing conditions in the merger agreement with somanta Pharmaceuticals, Inc. and applicable regulatory an... Form 10-KSB and other reports filed by Access and somanta with the Securities and Exchange Commission. ...

Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference

...r agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to n...he closing conditions in the merger agreement with somanta Pharmaceuticals, Inc. and applicable regulatory an... Form 10-KSB and other reports filed by Access and somanta with the Securities and Exchange Commission. ...

Somanta Announces the Presentation of Alchemix Data at The American Association for Cancer Research Annual Meeting

...eutical company based in Dallas, Texas. About somanta Pharmaceuticals somanta Pharmaceuticals, Inc. ("Somanta") is a specialty o...date these forward-looking statements. Contact somanta Pharmaceuticals, Inc. Terrance J. Bruggeman Exec...

Somanta in Biological Technology

Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO

...ion of a definitive merger agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to numerous closing condition...manta's Annual Reports on Form 10-KSB and other reports filed by Access and somanta with the Securities and Exchange Commission. ...

Access Pharmaceuticals Announces $19.5 Million Recapitalization

...ion of a definitive merger agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to numerous closing condition...manta's Annual Reports on Form 10-KSB and other reports filed by Access and somanta with the Securities and Exchange Commission. ...

Access Highlighted in Recent BusinessWeek Article

...ventis. The article references certain products of somanta Pharmaceuticals in the cancer area. While Access h...r agreement to acquire Somanta. The acquisition of somanta has not yet closed and the closing is subject to n...he closing conditions in the merger agreement with somanta Pharmaceuticals, Inc. and applicable regulatory an...